SMT201600031B - Composti eterociclici di fenossimetile - Google Patents

Composti eterociclici di fenossimetile

Info

Publication number: SMT201600031B
Authority: SM; San Marino
Prior art keywords: phenossimethyl; heterocyclic compounds; heterocyclic; compounds
Prior art date: 2009-05-07

Application number

SM201600031T

Other languages

English (en)

Inventor

Gideon Shapiro

Amy Ripka

Richard Chesworth

Original Assignee

Forum Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-05-07

Filing date

2016-02-04

Publication date

2016-02-25

2016-02-04 Application filed by Forum Pharmaceuticals Inc filed Critical Forum Pharmaceuticals Inc

2016-02-25 Publication of SMT201600031B publication Critical patent/SMT201600031B/it

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Psychiatry (AREA)
Obesity (AREA)
Hematology (AREA)
Psychology (AREA)
Endocrinology (AREA)
Addiction (AREA)
Emergency Medicine (AREA)
Hospice & Palliative Care (AREA)
Child & Adolescent Psychology (AREA)
Pain & Pain Management (AREA)
Reproductive Health (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Hydrogenated Pyridines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

SM201600031T 2009-05-07 2016-02-04 Composti eterociclici di fenossimetile SMT201600031B (it)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US17641309P	2009-05-07	2009-05-07
EP09796217A EP2427454B1 (en)	2009-05-07	2009-12-18	Phenoxymethyl heterocyclic compounds

Publications (1)

Publication Number	Publication Date
SMT201600031B true SMT201600031B (it)	2016-02-25

Family

ID=41549054

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SM201300070T SMT201300070B (it)	2009-05-07	2013-06-20	Composti eterociclici di fenossimetile
SM201600031T SMT201600031B (it)	2009-05-07	2016-02-04	Composti eterociclici di fenossimetile

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
SM201300070T SMT201300070B (it)	2009-05-07	2013-06-20	Composti eterociclici di fenossimetile

Country Status (32)

Country	Link
US (3)	US8343973B2 (it)
EP (3)	EP2617420B1 (it)
JP (2)	JP5628902B2 (it)
KR (1)	KR101662699B1 (it)
CN (2)	CN105125547A (it)
AU (1)	AU2009345802B2 (it)
BR (1)	BRPI0924617A8 (it)
CA (1)	CA2761032A1 (it)
CL (1)	CL2011002792A1 (it)
CO (1)	CO6460744A2 (it)
CR (1)	CR20110648A (it)
DK (2)	DK2427454T3 (it)
EC (1)	ECSP11011479A (it)
ES (2)	ES2409404T3 (it)
HR (2)	HRP20130482T1 (it)
HU (1)	HUE026238T2 (it)
IL (2)	IL216149A (it)
ME (1)	ME02375B (it)
MX (1)	MX2011011755A (it)
MY (1)	MY183910A (it)
NZ (1)	NZ596753A (it)
PE (1)	PE20120900A1 (it)
PH (1)	PH12013501321B1 (it)
PL (2)	PL2617420T3 (it)
PT (2)	PT2427454E (it)
RS (2)	RS52838B (it)
RU (1)	RU2531274C2 (it)
SG (1)	SG175900A1 (it)
SI (2)	SI2617420T1 (it)
SM (2)	SMT201300070B (it)
WO (1)	WO2010128995A1 (it)
ZA (1)	ZA201108920B (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2009262241B2 (en)	2008-06-25	2014-05-22	Forum Pharmaceuticals Inc.	1, 2 disubstituted heterocyclic compounds
ME02375B (me)	2009-05-07	2016-06-20	Forum Pharmaceuticals Inc	Heterociklički spojevi fenoksilmetila
US8772316B2 (en)	2011-02-18	2014-07-08	Allergan, Inc.	Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A)
SG11201408324QA (en)	2012-06-12	2015-01-29	Abbvie Inc	Pyridinone and pyridazinone derivatives
WO2014071044A1 (en)	2012-11-01	2014-05-08	Allergan, Inc.	Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a)
ES2480341B1 (es)	2013-01-24	2015-01-22	Palobiofarma S.L	Nuevos derivados de pirimidina como inhibidores de la fosfodiesterasa 10 (PDE-10)
TW201512201A (zh) *	2013-03-14	2015-04-01	Forum Pharmaceuticals Inc	化合物的多晶型及鹽類
TWI634114B (zh) *	2013-05-08	2018-09-01	永恒生物科技公司	作為激酶抑制劑之呋喃酮化合物
WO2015006689A1 (en)	2013-07-12	2015-01-15	University Of South Alabama	Treatment and diagnosis of cancer and precancerous conditions using pde10a inhibitors and methods to measure pde10a expression
US9200016B2 (en)	2013-12-05	2015-12-01	Allergan, Inc.	Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
US11034669B2 (en)	2018-11-30	2021-06-15	Nuvation Bio Inc.	Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CZ20021548A3 (cs) *	1999-11-05	2002-10-16	Societe De Conseils De Recherches Et D'application	Nové heterocyklické sloučeniny a jejich pouľití jako léků
US20030032579A1 (en)	2001-04-20	2003-02-13	Pfizer Inc.	Therapeutic use of selective PDE10 inhibitors
EP1541149A1 (en)	2002-06-26	2005-06-15	Kyowa Hakko Kogyo Co., Ltd.	Phosphodiesterase inhibitor
CN102491969B (zh) *	2005-01-07	2015-08-19	辉瑞产品公司	杂芳族喹啉化合物及其作为pde10抑制剂的用途
NL2000397C2 (nl) *	2006-01-05	2007-10-30	Pfizer Prod Inc	Bicyclische heteroarylverbindingen als PDE10 inhibitoren.
EP1845098A1 (en) *	2006-03-29	2007-10-17	Ferrer Internacional, S.A.	Imidazo[1,2-b]pyridazines, their processes of preparation and their use as GABA receptor ligands
US20090176829A1 (en) *	2006-05-02	2009-07-09	Pfizer Inc	Bicyclic heteroaryl compounds as pde10 inhibitors
WO2008033455A2 (en)	2006-09-13	2008-03-20	The Institutes For Pharmaceutical Discovery, Llc	Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors
FR2928924B1 (fr) *	2008-03-21	2010-04-23	Sanofi Aventis	Derives polysubstitues de 6-heteroaryle-imidazo°1,2-a! pyridines, leur preparation et leur application en therapeutique
AU2009262241B2 (en) *	2008-06-25	2014-05-22	Forum Pharmaceuticals Inc.	1, 2 disubstituted heterocyclic compounds
ME02375B (me)	2009-05-07	2016-06-20	Forum Pharmaceuticals Inc	Heterociklički spojevi fenoksilmetila
MX2012002596A (es) *	2009-09-03	2012-07-03	Allergan Inc	Compuestos como moduladores de tirosina cinasas.
EP3915367A1 (en) *	2010-08-18	2021-12-01	BioSplice Therapeutics, Inc.	Diketones and hydroxyketones as catenin signaling pathway activators

2009
- 2009-12-18 ME MEP-2015-210A patent/ME02375B/me unknown
- 2009-12-18 RS RS20130218A patent/RS52838B/sr unknown
- 2009-12-18 DK DK09796217.9T patent/DK2427454T3/da active
- 2009-12-18 PL PL13150322T patent/PL2617420T3/pl unknown
- 2009-12-18 CA CA2761032A patent/CA2761032A1/en not_active Abandoned
- 2009-12-18 EP EP13150322.9A patent/EP2617420B1/en active Active
- 2009-12-18 PL PL09796217T patent/PL2427454T3/pl unknown
- 2009-12-18 WO PCT/US2009/068644 patent/WO2010128995A1/en not_active Ceased
- 2009-12-18 MY MYPI2011005358A patent/MY183910A/en unknown
- 2009-12-18 ES ES09796217T patent/ES2409404T3/es active Active
- 2009-12-18 AU AU2009345802A patent/AU2009345802B2/en not_active Ceased
- 2009-12-18 DK DK13150322.9T patent/DK2617420T3/da active
- 2009-12-18 KR KR1020117028223A patent/KR101662699B1/ko not_active Expired - Fee Related
- 2009-12-18 RS RS20150803A patent/RS54529B1/sr unknown
- 2009-12-18 JP JP2012509778A patent/JP5628902B2/ja not_active Expired - Fee Related
- 2009-12-18 MX MX2011011755A patent/MX2011011755A/es active IP Right Grant
- 2009-12-18 BR BRPI0924617A patent/BRPI0924617A8/pt not_active IP Right Cessation
- 2009-12-18 HR HRP20130482AT patent/HRP20130482T1/hr unknown
- 2009-12-18 SI SI200931314T patent/SI2617420T1/sl unknown
- 2009-12-18 RU RU2011149637/04A patent/RU2531274C2/ru not_active IP Right Cessation
- 2009-12-18 CN CN201510438849.1A patent/CN105125547A/zh active Pending
- 2009-12-18 PE PE2011001918A patent/PE20120900A1/es not_active Application Discontinuation
- 2009-12-18 CN CN200980159735.6A patent/CN102459242B/zh not_active Expired - Fee Related
- 2009-12-18 US US12/642,026 patent/US8343973B2/en not_active Expired - Fee Related
- 2009-12-18 EP EP15184753.0A patent/EP3020716A1/en not_active Withdrawn
- 2009-12-18 NZ NZ596753A patent/NZ596753A/xx not_active IP Right Cessation
- 2009-12-18 PT PT97962179T patent/PT2427454E/pt unknown
- 2009-12-18 SI SI200930609T patent/SI2427454T1/sl unknown
- 2009-12-18 SG SG2011081437A patent/SG175900A1/en unknown
- 2009-12-18 ES ES13150322.9T patent/ES2554788T3/es active Active
- 2009-12-18 EP EP09796217A patent/EP2427454B1/en active Active
- 2009-12-18 PT PT131503229T patent/PT2617420E/pt unknown
- 2009-12-18 HU HUE13150322A patent/HUE026238T2/en unknown
2011
- 2011-11-03 IL IL216149A patent/IL216149A/en not_active IP Right Cessation
- 2011-11-07 CL CL2011002792A patent/CL2011002792A1/es unknown
- 2011-11-11 CO CO11153626A patent/CO6460744A2/es active IP Right Grant
- 2011-11-24 EC EC2011011479A patent/ECSP11011479A/es unknown
- 2011-12-05 CR CR20110648A patent/CR20110648A/es unknown
- 2011-12-05 ZA ZA2011/08920A patent/ZA201108920B/en unknown
2012
- 2012-12-20 US US13/722,595 patent/US8946222B2/en not_active Expired - Fee Related
2013
- 2013-06-20 PH PH12013501321A patent/PH12013501321B1/en unknown
- 2013-06-20 SM SM201300070T patent/SMT201300070B/it unknown
2014
- 2014-10-02 JP JP2014204220A patent/JP5943053B2/ja not_active Expired - Fee Related
- 2014-12-09 US US14/564,507 patent/US20150322069A1/en not_active Abandoned
2015
- 2015-11-25 HR HRP20151273TT patent/HRP20151273T1/hr unknown
2016
- 2016-02-04 SM SM201600031T patent/SMT201600031B/it unknown
- 2016-02-10 IL IL244059A patent/IL244059A0/en unknown

Also Published As

Publication number	Publication date
KR101662699B1 (ko)	2016-10-05
PH12013501321A1 (en)	2014-08-27
PE20120900A1 (es)	2012-08-14
CA2761032A1 (en)	2010-11-11
US8946222B2 (en)	2015-02-03
HK1167402A1 (en)	2012-11-30
HK1186981A1 (en)	2014-03-28
CN102459242B (zh)	2015-08-26
RS54529B1 (sr)	2016-06-30
HRP20151273T1 (hr)	2016-01-29
MY183910A (en)	2021-03-17
IL244059A0 (en)	2016-04-21
PL2427454T3 (pl)	2013-09-30
PT2427454E (pt)	2013-06-20
AU2009345802A1 (en)	2011-12-15
IL216149A (en)	2016-02-29
NZ596753A (en)	2013-09-27
ES2554788T3 (es)	2015-12-23
PL2617420T3 (pl)	2016-04-29
EP2617420B1 (en)	2015-09-23
US8343973B2 (en)	2013-01-01
EP2427454A1 (en)	2012-03-14
EP3020716A1 (en)	2016-05-18
MX2011011755A (es)	2012-03-16
US20130143888A1 (en)	2013-06-06
HUE026238T2 (en)	2016-06-28
ZA201108920B (en)	2012-08-29
KR20120027268A (ko)	2012-03-21
JP5628902B2 (ja)	2014-11-19
SG175900A1 (en)	2011-12-29
RU2531274C2 (ru)	2014-10-20
SI2617420T1 (sl)	2016-02-29
CN102459242A (zh)	2012-05-16
CL2011002792A1 (es)	2012-06-01
CR20110648A (es)	2012-03-28
ECSP11011479A (es)	2011-12-30
JP5943053B2 (ja)	2016-06-29
JP2015038112A (ja)	2015-02-26
JP2012526107A (ja)	2012-10-25
WO2010128995A1 (en)	2010-11-11
IL216149A0 (en)	2012-01-31
ME02375B (me)	2016-06-20
SI2427454T1 (sl)	2013-08-30
CN105125547A (zh)	2015-12-09
PH12013501321B1 (en)	2014-08-27
BRPI0924617A8 (pt)	2017-10-03
DK2427454T3 (da)	2013-06-17
RU2011149637A (ru)	2013-06-20
RS52838B (sr)	2013-10-31
DK2617420T3 (da)	2015-12-07
CO6460744A2 (es)	2012-06-15
ES2409404T3 (es)	2013-06-26
PT2617420E (pt)	2015-12-18
SMT201300070B (it)	2013-09-06
US20100292238A1 (en)	2010-11-18
US20150322069A1 (en)	2015-11-12
AU2009345802B2 (en)	2016-05-26
EP2427454B1 (en)	2013-03-20
EP2617420A1 (en)	2013-07-24
BRPI0924617A2 (it)	2017-07-11
HRP20130482T1 (en)	2013-08-31

Publication	Publication Date	Title
SMT201600075B (it)	2016-04-29	Composto di diamminocarbossammide eterociclica
HUE043536T2 (hu)	2019-08-28	PDK1 inhibitorként alkalmazható heterociklusos vegyületek
SMT201600267B (it)	2016-08-31	Inibitori di syk imidazopirazinici
SMT201600008B (it)	2016-02-25	Composti di piridazinone
DK2540728T3 (da)	2019-05-13	Heterocyklisk forbindelse
DOP2012000114A (es)	2012-08-15	Inhibidor bromodominio de benzodiazepina
BR112012005616A2 (pt)	2016-06-21	compostos antivirais heterocíclicos
EP2485589A4 (en)	2013-02-06	HETEROARYL-BTK INHIBITORS
SMT201600291B (it)	2016-11-10	Inibitori di proteasi hcv
SMT201600031B (it)	2016-02-25	Composti eterociclici di fenossimetile
BRPI1010852A2 (pt)	2019-09-24	compostos antivirais heterocíclicos
DK2427449T3 (da)	2013-04-22	Vinylindazolylforbindelser
BR112012006859A2 (pt)	2019-09-24	compostos
SMT201900049T1 (it)	2019-02-28	Composti eterociclici e loro utilizzi
BR112012008061A2 (pt)	2016-03-01	compostos de oxima heterocíclica
EP2604601A4 (en)	2013-11-27	HETERO RING CONNECTION
BRPI0906705A2 (pt)	2015-06-30	Composto heterocíclicos
PL2493466T3 (pl)	2021-11-15	Nowe przeciwguzowe zastosowanie kabazytakselu
BRPI1016266A2 (pt)	2019-09-24	compostos antivirais heterocíclicos
UY33156A (es)	2011-07-29	Nuevos compuestos tienopirrol
UY33155A (es)	2011-07-29	Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa
BRPI0925050A2 (pt)	2015-08-04	Compostos heterocíclicos como inibidores de mek
BR112012002336A2 (pt)	2016-05-31	compostos aza-heterocíclicos
SMT201500268B (it)	2016-01-08	Derivato di 5-idrossipirimidin-4-carbossammide
BR112013010643A2 (pt)	2016-08-09	compostos heterocíclicos